featured
FDA Panel Says No to Experimental ALS Drug
FDA advisors voted overwhelmingly to recommend against approval of experimental stem cell treatment, saying it showed a lack of efficacy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.